Document is current
Any future updates will be listed below
-
Authors
Berquez, Marine
Chen, Zhiyong https://orcid.org/0000-0003-0203-2930
Festa, Beatrice Paola
Krohn, Patrick
Keller, Svenja Aline
Parolo, Silvia https://orcid.org/0000-0002-3671-5353
Korzinkin, Mikhail
Gaponova, Anna
Laczko, Endre https://orcid.org/0000-0003-0271-3971
Domenici, Enrico
Devuyst, Olivier https://orcid.org/0000-0003-3744-4767
Luciani, Alessandro https://orcid.org/0000-0001-7219-3719
-
Funding
Funding for this research was provided by:
Cystinosis Research Foundation (CRFS-2017-007, CRFS-2020-005)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (project grant 310030_215715)
University Research Priority Program of the University of Zurich (URPP) ITINERARE—Innovative Therapies in Rare Diseases
- License Information
-
More Information
Article History
Received: 27 June 2022
Accepted: 6 June 2023
First Online: 14 July 2023
Competing interests
: M.K. and A.G. are affiliated with Insilico Medicine, a commercial company developing AI solutions for aging research, drug discovery, and longevity medicine. The authors declare no competing interests.
